Placental response to maternal SARS-CoV-2 infection

[1]  M. Benndorf,et al.  Living systematic review and meta-analysis of the prostate MRI diagnostic test with Prostate Imaging Reporting and Data System (PI-RADS) assessment for the detection of prostate cancer: study protocol , 2022, BMJ Open.

[2]  Y. Sadovsky,et al.  Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin , 2021, mSphere.

[3]  Jasmine Rah,et al.  Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients , 2021, American Journal of Obstetrics and Gynecology.

[4]  Jeffrey S. Morris,et al.  Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. , 2021, JAMA pediatrics.

[5]  D. Schwartz,et al.  Chronic Histiocytic Intervillositis with Trophoblast Necrosis are Risk Factors Associated with Placental Infection from Coronavirus Disease 19 (COVID-19) and Intrauterine Maternal-Fetal Systemic Acute Respiratory Coronavirus 2 (SARSCoV-2) Transmission in Liveborn and Stillborn Infants. , 2020, Archives of pathology & laboratory medicine.

[6]  D. Lauffenburger,et al.  Compromised SARS-CoV-2-specific placental antibody transfer , 2020, Cell.

[7]  A. Uhlemann,et al.  Trophoblast damage with acute and chronic intervillositis: disruption of the placental barrier by severe acute respiratory syndrome coronavirus 2☆ , 2020, Human Pathology.

[8]  E. Kudryashova,et al.  Opposing activities of IFITM proteins in SARS‐CoV‐2 infection , 2020, The EMBO journal.

[9]  Jesse M. Fajnzylber,et al.  Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic , 2020, JAMA network open.

[10]  N. Grandvaux,et al.  ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities , 2020, eLife.

[11]  Y. Matsuura,et al.  The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN , 2020, bioRxiv.

[12]  G. Altan-Bonnet,et al.  β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway , 2020, Cell.

[13]  F. Kirchhoff,et al.  SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans , 2020, mBio.

[14]  G. Xiong,et al.  Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection on Pregnant Women and Their Infants , 2020 .

[15]  M. Neovius,et al.  Association of SARS-CoV-2 Test Status and Pregnancy Outcomes. , 2020, JAMA.

[16]  Peter B Rosenthal,et al.  Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion , 2020, Nature.

[17]  L. Mofenson,et al.  Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis , 2020, BMJ.

[18]  E. Barnett,et al.  Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads , 2020, Placenta.

[19]  A. Heazell,et al.  A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection , 2020, Placenta.

[20]  M. Jolly,et al.  Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2 , 2020, Frontiers in Cell and Developmental Biology.

[21]  E. Kudryashova,et al.  Opposing activities of IFITM proteins in SARS-CoV-2 infection , 2020, bioRxiv.

[22]  X. Wan,et al.  Placental SARS‐CoV‐2 in a pregnant woman with mild COVID‐19 disease , 2020, Journal of medical virology.

[23]  D. Roberts,et al.  SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers , 2020, Modern Pathology.

[24]  H. Taylor,et al.  Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis , 2020, American Journal of Obstetrics and Gynecology.

[25]  Juping Yuan,et al.  A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2 , 2020, Cells.

[26]  C. Rice,et al.  LY6E impairs coronavirus fusion and confers immune control of viral disease , 2020, Nature Microbiology.

[27]  J. Sodroski,et al.  Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike , 2020, Nature.

[28]  R. Wapner,et al.  Conducting research during the COVID-19 pandemic , 2020, Seminars in Perinatology.

[29]  M. Baldewijns,et al.  Vertical transmission of SARS-CoV-2 infection and preterm birth , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[30]  D. Rakheja,et al.  INTRAUTERINE TRANSMISSION OF SARS-COV-2 INFECTION IN A PRETERM INFANT. , 2020, The Pediatric infectious disease journal.

[31]  H. Krumholz,et al.  Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.

[32]  S. Farhadian,et al.  SARS-CoV-2 infection of the placenta. , 2020, The Journal of clinical investigation.

[33]  Siobhan M. Dolan,et al.  Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers. , 2020, Obstetrics and gynecology.

[34]  J. Dorling,et al.  Maternal transmission of SARS‐COV‐2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis , 2020, BJOG : an international journal of obstetrics and gynaecology.

[35]  R. Carvalho,et al.  Prediction of Non-canonical Routes for SARS-CoV-2 Infection in Human Placenta Cells , 2020, bioRxiv.

[36]  S. Chauhan,et al.  Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review. , 2020, Obstetrics and gynecology.

[37]  S. Hansson,et al.  Complicated COVID-19 in pregnancy: a case report with severe liver and coagulation dysfunction promptly improved by delivery , 2020, BMC Pregnancy and Childbirth.

[38]  P. Brocklehurst,et al.  Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study , 2020, BMJ.

[39]  Russell S. Miller,et al.  Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection. , 2020, Obstetrics and gynecology.

[40]  J. Goldstein,et al.  Placental Pathology in COVID-19 , 2020, American journal of clinical pathology.

[41]  R. Pique-Regi,et al.  Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? , 2020, bioRxiv.

[42]  A. Benachi,et al.  Transplacental transmission of SARS-CoV-2 infection , 2020, Nature Communications.

[43]  Victor G. Puelles,et al.  Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.

[44]  A. Vintzileos,et al.  Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy , 2020, American Journal of Obstetrics and Gynecology.

[45]  D. Heller,et al.  Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings , 2020, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[46]  J. Goldstein,et al.  Placental pathology in COVID-19 , 2020, medRxiv.

[47]  A. Roman,et al.  Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples , 2020, American Journal of Obstetrics & Gynecology Mfm.

[48]  S. Srinivas,et al.  Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study , 2020, American Journal of Obstetrics & Gynecology MFM.

[49]  M. Merad,et al.  Immunology of COVID-19: Current State of the Science , 2020, Immunity.

[50]  Gilbert GREUB,et al.  Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection. , 2020, JAMA.

[51]  J. Knight,et al.  Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019 , 2020, The Journal of infectious diseases.

[52]  M. Hoffmann,et al.  A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells , 2020, Molecular Cell.

[53]  Fabian J Theis,et al.  SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes , 2020, Nature Medicine.

[54]  Liang Chen,et al.  The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study , 2020, PloS one.

[55]  Dena Goffman,et al.  Universal Screening for SARS-CoV-2 in Women Admitted for Delivery , 2020, The New England journal of medicine.

[56]  Y. Diambomba,et al.  Classification system and case definition for SARS‐CoV‐2 infection in pregnant women, fetuses, and neonates , 2020, Acta obstetricia et gynecologica Scandinavica.

[57]  H. Zeng,et al.  LY6E Restricts the Entry of Human Coronaviruses, including the currently pandemic SARS-CoV-2 , 2020, bioRxiv.

[58]  Lingkong Zeng,et al.  Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China. , 2020, JAMA pediatrics.

[59]  Shenmin Zhang,et al.  FcRn, but not FcγRs, drives maternal-fetal transplacental transport of human IgG antibodies , 2020, Proceedings of the National Academy of Sciences.

[60]  Abraham J. Koster,et al.  A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis , 2020, bioRxiv.

[61]  Fabian J Theis,et al.  SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues , 2020, SSRN Electronic Journal.

[62]  M. Lipsitch,et al.  Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.

[63]  C. Rice,et al.  LY6E impairs coronavirus fusion and confers immune control of viral disease , 2020, Nature Microbiology.

[64]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[65]  Qiang Zhou,et al.  Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.

[66]  J. Low,et al.  Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. , 2020, JAMA.

[67]  S. Permar,et al.  Maternal gatekeepers: How maternal antibody Fc characteristics influence passive transfer and infant protection , 2020, PLoS pathogens.

[68]  Liang Chen,et al.  The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single cell transcriptome study , 2020, bioRxiv.

[69]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[70]  M. Letko,et al.  Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.

[71]  R. Casazza,et al.  Protective and Pathogenic Effects of Interferon Signaling During Pregnancy. , 2020, Viral immunology.

[72]  J. Sodroski,et al.  SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease , 2020, bioRxiv.

[73]  Temet M McMichael,et al.  Interferon-induced transmembrane proteins inhibit cell fusion mediated by trophoblast syncytins , 2019, The Journal of Biological Chemistry.

[74]  T. Heidmann,et al.  IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise , 2019, Science.

[75]  Xinxia Peng,et al.  Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women , 2019, Cell.

[76]  M. Diamond,et al.  Immune responses at the maternal-fetal interface , 2019, Science Immunology.

[77]  Jinhong Chang,et al.  Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses , 2017, Journal of Virology.

[78]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[79]  C. Jones,et al.  Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy , 2017, Front. Immunol..

[80]  Y. Sadovsky,et al.  Determinants of effective lentivirus-driven microRNA expression in vivo , 2016, Scientific Reports.

[81]  J. Kwon,et al.  Viral Infections During Pregnancy , 2015, American journal of reproductive immunology.

[82]  M. Farzan,et al.  IFITM-Family Proteins: The Cell's First Line of Antiviral Defense. , 2014, Annual review of virology.

[83]  A. Javed,et al.  Medicare readmission penalties in Detroit. , 2014, The New England journal of medicine.

[84]  D. Jamieson,et al.  Pregnancy and infection. , 2014, The New England journal of medicine.

[85]  Johannes B. Goll,et al.  Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. , 2014, JAMA.

[86]  Fei Liu,et al.  Interferon induction of IFITM proteins promotes infection by human coronavirus OC43 , 2014, Proceedings of the National Academy of Sciences.

[87]  P. Kellam,et al.  IFITM proteins — cellular inhibitors of viral entry , 2014, Current Opinion in Virology.

[88]  D. Stolz,et al.  Human placental trophoblasts confer viral resistance to recipient cells , 2013, Proceedings of the National Academy of Sciences.

[89]  Dayan Wang,et al.  Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals , 2013, Nature Communications.

[90]  M. Diamond,et al.  The broad-spectrum antiviral functions of IFIT and IFITM proteins , 2012, Nature Reviews Immunology.

[91]  M. Farzan,et al.  Ifitm3 Limits the Severity of Acute Influenza in Mice , 2012, PLoS pathogens.

[92]  Paul Kellam,et al.  IFITM3 restricts the morbidity and mortality associated with influenza , 2012, Nature.

[93]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[94]  Krishna Shankara Narayanan,et al.  SARS Coronavirus nsp1 Protein Induces Template-Dependent Endonucleolytic Cleavage of mRNAs: Viral mRNAs Are Resistant to nsp1-Induced RNA Cleavage , 2011, PLoS pathogens.

[95]  R. Callister,et al.  The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis? , 2011, Placenta.

[96]  A. Brass,et al.  Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus , 2011, PLoS pathogens.

[97]  David J. Adams,et al.  The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus , 2009, Cell.

[98]  J. Penninger,et al.  Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. , 2006, Placenta.

[99]  J. Li,et al.  Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix , 2005, Heredity.

[100]  Y. Sadovsky,et al.  The correlation between sampling site and gene expression in the term human placenta. , 2005, Placenta.

[101]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[102]  J. M. Osborne,et al.  Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. , 1996, Journal of immunology.

[103]  J. S. Hunt,et al.  An IgG‐transporting Fc receptor expressed in the syncytiotrophoblast of human placenta , 1996, European journal of immunology.

[104]  P. Staeheli,et al.  Partial inhibition of vesicular stomatitis virus by the interferon-induced human 9-27 protein. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[105]  G. Stark,et al.  Molecular analysis of a human interferon-inducible gene family. , 1991, European journal of biochemistry.

[106]  J. August,et al.  Lysosome-associated membrane proteins: characterization of LAMP-1 of macrophage P388 and mouse embryo 3T3 cultured cells. , 1985, Archives of biochemistry and biophysics.

[107]  D. Freeman,et al.  Deaths from Asian influenza associated with pregnancy. , 1959, American journal of obstetrics and gynecology.

[108]  Clinical Spectrum of SARS-CoV-2 Infection , 2022 .

[109]  R. Clay.  Conducting research during the COVID-19 pandemic , 2020, PsycEXTRA Dataset.

[110]  Kheir M. Al-Kodmany.  Preliminary Findings , 2020, The Urban Book Series.

[111]  Sara Invitto,et al.  Current state of the science , 2015 .

[112]  Stephen J. Elledge,et al.  Supplemental Data The IFITM Proteins Mediate Cellular Resistance to Influenza A H 1 N 1 Virus , West Nile Virus , and Dengue Virus , 2009 .

[113]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.